High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury
- PMID: 27673428
- PMCID: PMC6436020
- DOI: 10.1089/neu.2016.4596
High-Mobility Group Box 1 (HMGB1) Is Elevated Systemically in Persons with Acute or Chronic Traumatic Spinal Cord Injury
Abstract
Inflammation in traumatic spinal cord injury (SCI) has been proposed to promote damage acutely and oppose functional recovery chronically. However, we do not yet understand the signals that initiate or prolong inflammation in persons with SCI. High-Mobility Group Box 1 (HMGB1) is a potent systemic inflammatory cytokine-or damage-associated molecular pattern molecule (DAMP)-studied in a variety of clinical settings. It is elevated in pre-clinical models of traumatic spinal cord injury (SCI), where it promotes secondary injury, and strategies that block HMGB1 improve functional recovery. To investigate the potential translational relevance of these observations, we measured HMGB1 in plasma from adults with acute (≤ 1 week post-SCI, n = 16) or chronic (≥ 1 year post-SCI, n = 47) SCI. Plasma from uninjured persons (n = 51) served as controls for comparison. In persons with acute SCI, average HMGB1 levels were significantly elevated within 0-3 days post-injury (6.00 ± 1.8 ng/mL, mean ± standard error of the mean [SEM]) or 4-7 (6.26 ± 1.3 ng/mL, mean ± SEM), compared with controls (1.26 ± 0.24 ng/mL, mean ± SEM; p ≤ 0.001 and p ≤ 0.01, respectively). In persons with chronic SCI who were injured for 15 ± 1.5 years (mean ± SEM), HMGB1 also was significantly elevated, compared with uninjured persons (3.7 ± 0.69 vs. 1.26 ± 0.24 ng/mL, mean ± SEM; p ≤ 0.0001). Together, these data suggest that HMGB1 may be a common, early, and persistent danger signal promoting inflammation in individuals with SCI.
Keywords: damage-associated molecular pattern; high mobility group box 1; inflammation; spinal cord injury.
Conflict of interest statement
For Angelos Papatheodorou, Katie Gibbs, Cristina Sison, Peter Davies and Matthew Bank, no competing financial interests exist.
For Ona Bloom, no competing financial interests exist; however, she received grants from the Craig H. Neilsen Foundation and the New York State Empire Clinical Research Investigator Program, and her institution received a grant from National Center for Research Resources during the conduct of the study. Dr. Bloom received an honorarium from the Craig H. Neilsen Foundation for membership on a peer review panel, outside the submitted work.
For Adam Stein, no competing financial interests exist; however, he reports personal fees from the Craig H. Neilsen Foundation, Stem Cells Inc., and In Vivo Therapeutics outside the submitted work. No compensation is associated with his board membership in the following organizations: Association of Academic Physiatrists and American Spinal Injury Association.
Figures
References
-
- National Spinal Cord Injury Statistical Center. (2016). Spinal Cord Injury (SCI) Facts and Figures at a Glance. University of Alabama: Birmingham
-
- Kwon B.K., Stammers A.M., Belanger L.M., Bernardo A., Chan D., Bishop C.M., Slobogean G.P., Zhang H., Umedaly H., Giffin M., Street J., Boyd M.C., Paquette S.J., Fisher C.G., and Dvorak M.F. (2010). Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury. J. Neurotrauma 27, 669–682 - PubMed
-
- Kwon B.K., Casha S., Hurlbert R.J., and Yong V.W. (2011). Inflammatory and structural biomarkers in acute traumatic spinal cord injury. Clin. Chem. Lab. Med. 49, 425–433 - PubMed
-
- Pouw M.H., Kwon B.K., Verbeek M.M., Vos P.E., van Kampen A., Fisher C.G., Street J., Paquette S.J., Dvorak M.F., Boyd M.C., Hosman A.J., and van de Meent H. (2014). Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects. Spinal Cord 52, 428–433 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
